These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35236765)

  • 21. Echocardiographic assessment of mitral stenosis and its associated valvular lesions in 205 patients and lack of association with mitral valve prolapse.
    Sagie A; Freitas N; Chen MH; Marshall JE; Weyman AE; Levine RA
    J Am Soc Echocardiogr; 1997 Mar; 10(2):141-8. PubMed ID: 9083969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular magnetic resonance imaging for valvular heart disease.
    Morello A; Gelfand EV
    Curr Heart Fail Rep; 2009 Sep; 6(3):160-6. PubMed ID: 19723457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Echocardiographic versus histologic findings in Marfan syndrome.
    Gu X; He Y; Li Z; Han J; Chen J; Nixon JV
    Tex Heart Inst J; 2015 Feb; 42(1):30-4. PubMed ID: 25873795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of Doppler echocardiography in the management of patients with valvular heart disease: analysis of one year of clinical practice.
    van den Brink RB; Verheul HA; Hoedemaker G; Düren DR; Reedijk M; Visser CA; Dunning AJ
    J Am Soc Echocardiogr; 1991; 4(2):109-20. PubMed ID: 2036223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valvular Heart Disease in Adults: Management of Native Valve Disease.
    Zhang X; Hollenberg SM
    FP Essent; 2017 Jun; 457():17-22. PubMed ID: 28671805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valvular heart disease.
    Carabello BA; Crawford FA
    N Engl J Med; 1997 Jul; 337(1):32-41. PubMed ID: 9203430
    [No Abstract]   [Full Text] [Related]  

  • 27. Comprehensive Nursing Management for Valvular Disease.
    Lee S
    Crit Care Nurs Clin North Am; 2019 Mar; 31(1):31-38. PubMed ID: 30736933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress echocardiography beyond coronary artery disease.
    Schwammenthal E; Vered Z; Rabinowitz B; Kaplinsky E; Feinberg MS
    Eur Heart J; 1997 Jun; 18 Suppl D():D130-7. PubMed ID: 9183622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptoms, exercise capacity and exercise hemodynamics: interrelationships and their role in quantification of the valvular lesion.
    Kraus F; Rudolph W
    Herz; 1984 Aug; 9(4):187-99. PubMed ID: 6479829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.
    Cheitlin MD; Douglas PS; Parmley WW
    J Am Coll Cardiol; 1994 Oct; 24(4):874-80. PubMed ID: 7930219
    [No Abstract]   [Full Text] [Related]  

  • 31. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.
    Cheitlin MD; Douglas PS; Parmley WW
    Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S254-60. PubMed ID: 7934748
    [No Abstract]   [Full Text] [Related]  

  • 32. The preoperative assessment of patients with valvular heart disease as a comorbidity.
    Markovi D; Janković R; Kovadević-Kostić N; Velinović M; Vranes M; Ivanović B
    Acta Chir Iugosl; 2011; 58(2):31-7. PubMed ID: 21879648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise Participation for Patients with Valvular Heart Disease: a Review of the Current Guidelines.
    Fernandez AB; Thompson PD
    Curr Cardiol Rep; 2021 Mar; 23(5):49. PubMed ID: 33740173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and echocardiographic assessment of pregnant women with valvular heart diseases--maternal and fetal outcome.
    Leśniak-Sobelga A; Tracz W; KostKiewicz M; Podolec P; Pasowicz M
    Int J Cardiol; 2004 Mar; 94(1):15-23. PubMed ID: 14996469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of valvular heart disease. Why echocardiography is an essential component.
    Assi ER; Tak T
    Postgrad Med; 1998 Dec; 104(6):99-102, 105-6, 109-10. PubMed ID: 9861259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valvular heart disease and pregnancy part I: native valves.
    Elkayam U; Bitar F
    J Am Coll Cardiol; 2005 Jul; 46(2):223-30. PubMed ID: 16022946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical use of two-dimensional echocardiography in mitral and aortic valve diseases].
    Tracz W; Krzemińska-Pakuła M; Dziatkowiak A; Czuma M; Kostkiewicz M; Borowiecka B; Pieniazek P
    Pol Arch Med Wewn; 1982; 67(5-6):273-82. PubMed ID: 6757886
    [No Abstract]   [Full Text] [Related]  

  • 38. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise testing in patients with aortic and mitral valve disease: current applications.
    Hochreiter C; Borer JS
    Cardiovasc Clin; 1983; 13(3):291-300. PubMed ID: 6349805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive methods are reliable for quantification of valvular stenoses and regurgitation.
    Burckhardt D; Amann FW; Hoffmann A
    Z Kardiol; 1986; 75 Suppl 2():1-12. PubMed ID: 2941925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.